| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/01/2006 | US20060115878 Method for producing L-amino acid |
| 06/01/2006 | US20060115877 Hyaluronate synthase gene and uses thereof |
| 06/01/2006 | US20060115874 Enrichment method for variant proteins with altered binding properties |
| 06/01/2006 | US20060115864 Identifying modulators of ubiquitin-mediated proteolysis; treatment and prevention of cell proliferative, arthritic and respiratory system disorders |
| 06/01/2006 | US20060115859 Tyrosylprotein sulfotransferases and methods of use thereof |
| 06/01/2006 | US20060115853 Polynucleotides, polypeptides and method for screening for useful dog candidates |
| 06/01/2006 | US20060115852 proteins or polypeptides comprising amino acid sequences, used for diagnosis and therapy of diseases associated with oncogenes, such as transcription and apoptosis |
| 06/01/2006 | US20060115823 For detecting entero-hemorrhagic Escherichia coli in clinical examinations, public health examinations, food evaluations and food poisoning examinations; oligonucleotides preferable for composing a rapid and specific gene testing reagent |
| 06/01/2006 | US20060115820 Primer and probe for detecting vibrio cholerae or vibrio mimicus and detection method using the same |
| 06/01/2006 | US20060115816 Splice variant cannabinoid receptor (cb1b) |
| 06/01/2006 | US20060115813 Intracellular signaling molecules |
| 06/01/2006 | US20060115807 Episomal expression system |
| 06/01/2006 | US20060115806 Global analysis of transposable elements as molecular markers of cancer |
| 06/01/2006 | US20060115545 Methods and means for the manufacture of hyaluronan |
| 06/01/2006 | US20060115497 Mycobacterium strains with modified erp gene and vaccine composition containing same |
| 06/01/2006 | US20060115496 Toxoplasma gondii proteins, nucleic acid molecules, and uses thereof |
| 06/01/2006 | US20060115493 Bacterial packaging strains useful for generation and production of recombinant double-stranded RNA nucleocapsids and uses thereof |
| 06/01/2006 | US20060115491 Vaccine delivery; attaching immunogenic determinant of heterologous polypeptide biodrug to the peptidoglycan microparticle on cell wall of a Gram-positive bacterium; improve the binding by treating the cell wall with acid solution to remove protein, lipotechoic, carbohydrates |
| 06/01/2006 | US20060115490 vaccines, immunogenic compositions; diagnostics, enzymatic studies and targets for antibiotics; for treating Staphylococcus aureus infection |
| 06/01/2006 | US20060115488 Identification of new CD8 epitopes from HIV-1 proteins with therapeutical and vaccinal properties against HIV infections |
| 06/01/2006 | US20060115476 Antibodies anti-c5 component of the complement system and their use |
| 06/01/2006 | US20060115470 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| 06/01/2006 | US20060115463 Composition of fibroblast or chondrocyte cells transfected or transduced with a gene encoding transforming growth factor beta 1 (TGF- beta 1) or bone morphogenetic protein 2 (BMP-2), and chondrocyte cells that have not been transfected with the gene; generating hyaline cartilage at a target site |
| 06/01/2006 | US20060115461 Apparatus and system having dry gene silencing compositions |
| 06/01/2006 | US20060115456 Replication-competent adenoviral vectors |
| 06/01/2006 | US20060115455 Therapeutic RNAi agents for treating psoriasis |
| 06/01/2006 | US20060115453 Methods and compositions for treating cellular proliferative diseases |
| 06/01/2006 | DE19910102B4 Proteinkonjugate, Verfahren, Vektoren, Proteine und DNA zu deren Herstellung, deren Verwendung, sowie Arzneimittel und Impfstoffe mit einem Gehalt derselben Protein conjugates, methods, vectors, proteins, and DNA for their preparation, their use, as well as drugs and vaccines containing the same |
| 06/01/2006 | DE10024334B4 Verfahren zum Einbringen von Nukleinsäure in eine Zelle (Transfektion) mittels Calciumphosphat A method for introducing nucleic acid into a cell (transfection) by means of calcium phosphate |
| 06/01/2006 | DE10016881B4 Gezielte Transfektion von Zellen mittels biotinyliertem Dendrimer Targeted transfection of cells using biotinylated dendrimer |
| 06/01/2006 | CA2626211A1 Humanised baculovirus |
| 06/01/2006 | CA2608936A1 Increase in yield by reducing gene expression |
| 06/01/2006 | CA2590512A1 Fusion protein comprising a bh3-domain of a bh3-only protein |
| 06/01/2006 | CA2589754A1 Yeast strain and screening method for identifying inhibitors of the expression of the hexose transporter genes by a positive phenotype |
| 06/01/2006 | CA2589487A1 Means and methods for detecting methylated dna |
| 06/01/2006 | CA2589208A1 Gene trap cassettes for random and targeted conditional gene inactivation |
| 06/01/2006 | CA2589191A1 Enhancer-containing gene trap vectors for random and targeted gene trapping |
| 06/01/2006 | CA2589164A1 Production of proteins |
| 06/01/2006 | CA2589158A1 Protein isolation and purification |
| 06/01/2006 | CA2589151A1 Method for directing nucleic acids to plastids |
| 06/01/2006 | CA2588464A1 Plant transformed with a nucleic acid encoding an osmads18-like polypeptide having increased yield and methods for making the same |
| 06/01/2006 | CA2587399A1 Cytokinin-sensing histidine kinases and methods of use |
| 06/01/2006 | CA2586126A1 Novel shuttle vector |
| 05/31/2006 | EP1662005A1 Enhancer-containing gene trap vectors for random and targeted gene trapping |
| 05/31/2006 | EP1662004A1 Method of efficiently constructing growth regulatory recombinant adenovirus vector and kit for the construction thereof |
| 05/31/2006 | EP1662003A2 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 05/31/2006 | EP1662002A1 Method of introducing gene into plant material |
| 05/31/2006 | EP1662001A2 Expression cassettes for root-preferential expression in plants |
| 05/31/2006 | EP1662000A2 Expression cassettes for guard cell-preferential expression in plants |
| 05/31/2006 | EP1661999A1 A method of preparing epitopes chimeric gene vaccine |
| 05/31/2006 | EP1661998A2 Antigenic polypeptides, antibodies binding thereto, nucleic acids encoding the antigens, and methods of use |
| 05/31/2006 | EP1661997A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/31/2006 | EP1661996A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/31/2006 | EP1661995A1 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 05/31/2006 | EP1661994A1 Therapeutic agent for NGF |
| 05/31/2006 | EP1661993A1 SLY1 inhibitors in organ, tissue and cell transplantation |
| 05/31/2006 | EP1661992A1 Method of screening for homologous recombination events |
| 05/31/2006 | EP1661991A1 Hepatocellular cancer-associated gene |
| 05/31/2006 | EP1661990A1 Polypeptide specific to liver cancer, polynucleotide encoding the polypeptide and rna molecule inhibiting the expression of the polypeptide |
| 05/31/2006 | EP1661985A1 Method of making sucrose phosphorylase(sp) heat-stable |
| 05/31/2006 | EP1661981A1 Yeast strain and screening method for identifying inhibitors of the expression of the hexose transporter genes by a positive phenotype |
| 05/31/2006 | EP1661912A1 Fusion protein comprising a BH3-domain of a BH3-only protein |
| 05/31/2006 | EP1661911A1 Protease-resistant seb variant and vaccine containing the same |
| 05/31/2006 | EP1661905A1 Novel artificial nucleic acids of n-o bond crosslinkage type |
| 05/31/2006 | EP1661456A1 Method of constructing nuclear-transplanted egg, parthenogenetic embryo and parthenogenetic mammal |
| 05/31/2006 | EP1660687A2 Rnai-based modification of heterochromatin |
| 05/31/2006 | EP1660685A2 Antisense inhibition of laminin-8 expression to inhibit human gliomas |
| 05/31/2006 | EP1660682A2 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION |
| 05/31/2006 | EP1660678A2 Mutant adeno-associated virus virions and methods of use thereof |
| 05/31/2006 | EP1660666A1 Vaccination vectors derived from lymphotropic human herpes viruses 6 and 7 |
| 05/31/2006 | EP1660665A2 Chimaeric vector system |
| 05/31/2006 | EP1660664A1 Poxvirus vector encoding prostate specific antigens for treatment of prostate cancer |
| 05/31/2006 | EP1660663A2 Methods and compositions for tissue repair |
| 05/31/2006 | EP1660662A1 Regulatable gene expression in mammalian cells and mammals |
| 05/31/2006 | EP1660661A2 Methods of protein production in yeast |
| 05/31/2006 | EP1660660A2 Polypeptides of streptococcus pyogenes |
| 05/31/2006 | EP1660658A2 The use of sirna silencing in the prevention of metastasis |
| 05/31/2006 | EP1660657A1 Interfering rna duplex having blunt-ends and 3'-modifications |
| 05/31/2006 | EP1660656A2 An antisense oligonucleotide to inhibit melanoma inhibitory activity, mia |
| 05/31/2006 | EP1660655A2 Look-through mutagenesis |
| 05/31/2006 | EP1660654A1 Expression vector |
| 05/31/2006 | EP1660649A1 Method for detoxification of mycotoxins |
| 05/31/2006 | EP1660646A2 Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use |
| 05/31/2006 | EP1660638A2 Lipoparticles comprising proteins, methods of making, and using the same |
| 05/31/2006 | EP1660637A2 Variants of glycoside hydrolases |
| 05/31/2006 | EP1660635A2 Methods and compositions comprising fatp5 for use in the diagnosis and treatment of metabolic disorders |
| 05/31/2006 | EP1660632A2 Human skin equivalents expressing exogenous polypeptides |
| 05/31/2006 | EP1660631A2 Compositions and methods for preparing short rna molecules and other nucleic acids |
| 05/31/2006 | EP1660628A2 SPLICE VARIANTS OF ErbB LIGANDS, COMPOSITIONS AND USES THEREOF |
| 05/31/2006 | EP1660535A2 Techniques and compositions for the diagnosis and treatment of cancer (muc1) |
| 05/31/2006 | EP1660534A2 Humanization of antibodies |
| 05/31/2006 | EP1660526A1 Gastric and prostate cancer associated antigens |
| 05/31/2006 | EP1660517A2 Nogo receptor antagonists |
| 05/31/2006 | EP1660514A2 A novel gene and protein associated with angiogenesis and endothelial apoptosis |
| 05/31/2006 | EP1660513A2 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 05/31/2006 | EP1660502A2 MODULATION OF ß-CATENIN/TCF ACTIVATED TRANSCRIPTION |
| 05/31/2006 | EP1660186A2 Humanization of antibodies |
| 05/31/2006 | EP1660136A2 Trefoil factor 3 (tff3) as a target for anti-cancer therapy |
| 05/31/2006 | EP1660127A1 Antibodies to c-met |
| 05/31/2006 | EP1660125A1 Composition for the prophylaxis/treatment of hbv infections and hbv-mediated diseases |